Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: FALMINA — Supplemental Application (Northstar Rx LLC)

View source ↗

Summary

FDA approved a supplemental application for Falmina, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submitted by Northstar Rx LL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FALMINA (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for FALMINA (LEVONORGESTREL AND ETHINYL ESTRADIOL)